Clinical Trials Browser

Breast Neoplasms, Carcinosarcoma, Colonic Neoplasms, Neoplasm Metastasis, Salivary Gland Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05007379 2026-03-18

CARMA

Recruiting

100 enrolled

Breast

Breast Neoplasms

NCT05020574 2026-03-18

Microbiome and Association With Implant Infections

Phase 2 Recruiting

200 enrolled

Breast

Breast Neoplasms, Genetic Predisposition to Disease

NCT05286684 2026-03-18

Exo-LCR

Phase NA Completed

7 enrolled

BreastCNS

Breast Neoplasms, Meningeal Carcinomatosis

NCT05629585 2026-03-18

A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

Phase 3 Active not recruiting

1,174 enrolled

Breast

Breast Neoplasms

NCT05654623 2026-03-18

VERITAC-2

Phase 3 Active not recruiting

624 enrolled 17 charts

Breast

Breast Neoplasms

NCT05743686 2026-03-18

App for Adverse Events to Oral Chemotherapy - Pilot Study

Phase NA Completed

28 enrolled

Breast

Breast Neoplasms

NCT05787834 2026-03-18

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer

Phase NA Recruiting

130 enrolled

Breast

Breast Neoplasms

NCT05941520 2026-03-18

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Phase 2 Recruiting

80 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06148038 2026-03-18

CBD for Breast Cancer Primary Tumors

Phase 1 Not yet recruiting

60 enrolled

Breast

Breast Neoplasms

NCT06324357 2026-03-18

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Phase 1/2 Recruiting

768 enrolled

BreastGastrointestinal

Adenocarcinoma Of Esophagus, Breast Neoplasms, Colorectal Neoplasms

NCT06377852 2026-03-18

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Phase 3 Recruiting

500 enrolled

Breast

Breast Neoplasms

NCT06428799 2026-03-18

EMBLEDDA-MMG

Completed

122 enrolled

Breast

Breast Neoplasms

NCT06590857 2026-03-18

TRACY-1

Phase 1/2 Active not recruiting

16 enrolled

Breast

Breast Neoplasms

NCT06625775 2026-03-18

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Phase 1 Recruiting

392 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT06833853 2026-03-18

CTC-EXPRESS

Recruiting

187 enrolled

Breast

Breast Neoplasms

NCT06900374 2026-03-18

RF-Vaginale

Phase NA Recruiting

75 enrolled

Breast

Breast Neoplasms

NCT06995898 2026-03-18

The Vanguard Study: Testing a New Way to Screen for Cancer

Phase NA Recruiting

24,000 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07015944 2026-03-18

Moving On ABC

Phase NA Recruiting

26,376 enrolled

Breast

Breast Neoplasms, Depression, Depressive Disorder, Major

NCT07137416 2026-03-18

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Phase 1 Recruiting

36 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07205822 2026-03-18

TB06

Phase 3 Recruiting

100 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT07222267 2026-03-18

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Phase 1 Recruiting

86 enrolled

Breast

Breast Neoplasms

Clinical Trials

ImmunoADAPT

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

FLAMINGO-01

EMPRESS

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Adaptation and Pilot Testing of a Mindfulness-Based Insomnia and Symptom Management Intervention for Women With Breast Cancer Receiving Treatment in Rural Medically Underserved Areas

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

ML-CardioTox

Living Well With Advanced Breast Cancer

A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer

Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors

CONFIRM

TAILORx

Study of Blood Samples in Patients With Breast Cancer

Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery

APAPI

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

RepriM

KALICOU3

CHACRY

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

KSF2

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Study of DF1001 in Patients With Advanced Solid Tumors

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

CARMA

Microbiome and Association With Implant Infections

Exo-LCR

A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

VERITAC-2

App for Adverse Events to Oral Chemotherapy - Pilot Study

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

CBD for Breast Cancer Primary Tumors

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

EMBLEDDA-MMG

TRACY-1

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

CTC-EXPRESS

RF-Vaginale

The Vanguard Study: Testing a New Way to Screen for Cancer

Moving On ABC

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

TB06

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors